{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:03:47Z","timestamp":1780376627308,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"DOI":"10.1186\/s41927-025-00579-8","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:51:46Z","timestamp":1761904306000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of HLA-DRB1 SE, anti-citrullinated protein antibodies and smoking on radiographic outcome in Greek patients with Rheumatoid Arthritis"],"prefix":"10.1186","volume":"9","author":[{"given":"Evangelia N.","family":"Mole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Tarassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Tsirogianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theophilos","family":"Athanassiades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Kitsiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diamanto","family":"Kouniaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sousana","family":"Gazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Vlachoyiannopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"issue":"9746","key":"579_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/s0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet (London England). 2010;376(9746):1094\u2013108. https:\/\/doi.org\/10.1016\/s0140-6736(10)60826-4.","journal-title":"Lancet (London England)"},{"issue":"5","key":"579_CR2","first-page":"849","volume":"31","author":"A Kavanaugh","year":"2004","unstructured":"Kavanaugh A, Han C, Bala M. Functional status and radiographic joint damage are associated with health economic outcomes in patients with rheumatoid arthritis. J Rheumatol. 2004;31(5):849\u201355. PMID:15124242.","journal-title":"J Rheumatol"},{"key":"579_CR3","doi-asserted-by":"publisher","first-page":"1759720x2311745","DOI":"10.1177\/1759720x231174534","volume":"15","author":"G Adami","year":"2023","unstructured":"Adami G, Fassio A, Pistillo F, Benini C, Viapiana O, Rossini M, et al. Factors associated with radiographic progression in rheumatoid arthritis starting biological diseases modifying anti-rheumatic drugs (bDMARDs). Ther Adv Musculoskelet Dis. 2023;15:1759720x231174534. https:\/\/doi.org\/10.1177\/1759720x231174534.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"Suppl 2","key":"579_CR4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/rheumatology\/XXXIV.suppl_2.74","volume":"34","author":"DM van der Heijde","year":"1995","unstructured":"van der Heijde DM. Joint erosions and patients with early rheumatoid arthritis. Br J Rheumatol. 1995;34(Suppl 2):74\u20138.","journal-title":"Br J Rheumatol"},{"issue":"8","key":"579_CR5","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/1529-0131(200008)43:8<1809::aid-anr17>3.0.co;2-d","volume":"43","author":"SM Proudman","year":"2000","unstructured":"Proudman SM, Conaghan PG, Richardson C, Griffiths B, Green MJ, McGonagle D, et al. Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone. Arthritis Rheum. 2000;43(8):1809\u201319. https:\/\/doi.org\/10.1002\/1529-0131(200008)43:8%3C1809::aid-anr17%3E3.0.co;2-d.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"579_CR6","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/rheumatology\/kel237","volume":"46","author":"KP Machold","year":"2006","unstructured":"Machold KP, Stamm TA, Nell VPK, Pflugbeil S, Aletaha D, Steiner G, et al. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiographic progression over the first years of disease. Rheumatology (Oxford). 2006;46(2):342\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/kel237.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"579_CR7","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1136\/annrheumdis-2012-202958","volume":"73","author":"A Kleyer","year":"2014","unstructured":"Kleyer A, Finzel S, Rech J, Manger B, Krieter M, Faustini F, et al. Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies. Ann Rheum Dis. 2014;73(5):854\u201360. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202958.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"579_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s11926-014-0419-6","volume":"16","author":"KD Deane","year":"2014","unstructured":"Deane KD. Preclinical rheumatoid arthritis (autoantibodies): an updated review. Curr Rheumatol Rep. 2014;16(5):419. https:\/\/doi.org\/10.1007\/s11926-014-0419-6.","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"579_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/ard-2022-223356","volume":"82","author":"JS Smolen","year":"2023","unstructured":"Smolen JS, Landew\u00e9 RBM, Bergstra SA, Kerschbaumer A, Sepriano A, Aletaha D, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Ann Rheum Dis. 2023;82(1):3\u201318. https:\/\/doi.org\/10.1136\/ard-2022-223356.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"579_CR10","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1136\/ard.2009.121160","volume":"69","author":"K Visser","year":"2010","unstructured":"Visser K, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Ronday HK, Seys PE, Kerstens PJ, et al. A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the best study. Ann Rheum Dis. 2010;69(7):1333\u20137. https:\/\/doi.org\/10.1136\/ard.2009.121160.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"579_CR11","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13075-017-1266-4","volume":"19","author":"K Albrecht","year":"2017","unstructured":"Albrecht K, Zink A. Poor prognostic factors guiding treatment decisions in rheumatoid arthritis patients: a review of data from randomized clinical trials and cohort studies. Arthritis Res Ther. 2017;19(1):68. https:\/\/doi.org\/10.1186\/s13075-017-1266-4.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"579_CR12","doi-asserted-by":"publisher","first-page":"R249","DOI":"10.1186\/ar4092","volume":"14","author":"B Fautrel","year":"2012","unstructured":"Fautrel B, Granger B, Combe B, Saraux A, Guillemin F, Le Loet X. Matrix to predict rapid radiographic progression of early rheumatoid arthritis patients from the community treated with methotrexate or leflunomide: results from the ESPOIR cohort. Arthritis Res Ther. 2012;14(6):R249. https:\/\/doi.org\/10.1186\/ar4092.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"579_CR13","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1080\/03009742.2020.1771761","volume":"49","author":"M Ziegelasch","year":"2020","unstructured":"Ziegelasch M, Boman A, Martinsson K, Thyberg I, Jacobs C, Nyh\u00e4ll-W\u00e5hlin BM, et al. Anti-cyclic citrullinated peptide antibodies are associated with radiographic damage but not disease activity in early rheumatoid arthritis diagnosed in 2006\u20132011. Scand J Rheumatol. 2020;49(6):434\u201342. https:\/\/doi.org\/10.1080\/03009742.2020.1771761.","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"579_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13075-018-1575-2","volume":"20","author":"E Rydell","year":"2018","unstructured":"Rydell E, Forslind K, Nilsson J, Jacobsson LTH, Turesson C. Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis. Arthritis Res Ther. 2018;20(1):82. https:\/\/doi.org\/10.1186\/s13075-018-1575-2.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"579_CR15","doi-asserted-by":"publisher","first-page":"e000172","DOI":"10.1136\/rmdopen-2015-000172","volume":"2","author":"G Akdemir","year":"2016","unstructured":"Akdemir G, Verheul MK, Heimans L, Wevers-de Boer KV, Goekoop-Ruiterman YP, van Oosterhout M, et al. Predictive factors of radiological progression after 2\u2005years of remission-steered treatment in early arthritis patients: a post hoc analysis of the IMPROVED study. RMD Open. 2016;2(1):e000172. https:\/\/doi.org\/10.1136\/rmdopen-2015-000172.","journal-title":"RMD Open"},{"issue":"1","key":"579_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/art.21575","volume":"54","author":"L Klareskog","year":"2006","unstructured":"Klareskog L, Stolt P, Lundberg K, K\u00e4llberg H, Bengtsson C, Grunewald J, et al. A new model for an etiology of rheumatoid arthritis: smoking May trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006;54(1):38\u201346. https:\/\/doi.org\/10.1002\/art.21575.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"579_CR17","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1002\/1529-0131(199910)42:10<2174::aid-anr19>3.0.co;2-g","volume":"42","author":"B Harrison","year":"1999","unstructured":"Harrison B, Thomson W, Symmons D, Ollier B, Wiles N, Payton T, et al. The influence of HLA-DRB1 alleles and rheumatoid factor on disease outcome in an inception cohort of patients with early inflammatory arthritis. Arthritis Rheum. 1999;42(10):2174\u201383. https:\/\/doi.org\/10.1002\/1529-0131(199910)42:10%3C2174::aid-anr19%3E3.0.co;2-g.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"579_CR18","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1002\/1529-0131(199908)42:8<1696::aid-anr19>3.0.co;2-k","volume":"42","author":"HS El-Gabalawy","year":"1999","unstructured":"El-Gabalawy HS, Goldbach-Mansky R, Smith D 2nd, Arayssi T, Bale S, Gulko P, et al. Association of HLA alleles and clinical features in patients with synovitis of recent onset. Arthritis Rheum. 1999;42(8):1696\u2013705. https:\/\/doi.org\/10.1002\/1529-0131(199908)42:8%3C1696::aid-anr19%3E3.0.co;2-k.","journal-title":"Arthritis Rheum"},{"key":"579_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1136\/ard.55.1.34","volume":"55","author":"K Eberhardt","year":"1996","unstructured":"Eberhardt K, Fex E, Johnson U, Wollheim F. Association of HLA DRB and DQB genes with 2 and 5 year outcome in rheumatoid arthritis. Ann Rheum Dis. 1996;55:34\u20139. https:\/\/doi.org\/10.1136\/ard.55.1.34.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"579_CR20","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1136\/annrheumdis-2014-205428","volume":"74","author":"C Hecht","year":"2015","unstructured":"Hecht C, Englbrecht M, Rech J, Schmidt S, Araujo E, Engelke K, et al. Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA. Ann Rheum Dis. 2015;74(12):2151\u20136. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205428.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"579_CR21","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.3390\/jcm14051529","volume":"14","author":"T Togashi","year":"2025","unstructured":"Togashi T, Ishihara R, Watanabe R, Shiomi M, Yano Y, Fujisawa Y, et al. Rheumatoid factor: diagnostic and prognostic performance and therapeutic implications in rheumatoid arthritis. J Clin Med. 2025;14(5):1529. https:\/\/doi.org\/10.3390\/jcm14051529.","journal-title":"J Clin Med"},{"issue":"2","key":"579_CR22","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1136\/ard.2009.113092","volume":"69","author":"SW Syversen","year":"2010","unstructured":"Syversen SW, Goll GL, van der Heijde D, Landew\u00e9 R, Lie BA, Odeg\u00e5rd S, et al. Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study. Ann Rheum Dis. 2010;69(2):345\u201351. https:\/\/doi.org\/10.1136\/ard.2009.113092.","journal-title":"Ann Rheum Dis"},{"key":"579_CR23","doi-asserted-by":"publisher","first-page":"802934","DOI":"10.3389\/fmed.2021.802934","volume":"8","author":"J Liu","year":"2021","unstructured":"Liu J, Gao J, Wu Z, Mi L, Li N, Wang Y, et al. Anti-citrullinated protein antibody Generation, Pathogenesis, clinical Application, and prospects. Front Med (Laussane). 2021;8:802934. https:\/\/doi.org\/10.3389\/fmed.2021.802934.","journal-title":"Front Med (Laussane)"},{"issue":"4","key":"579_CR24","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00296-019-04492-5","volume":"40","author":"J Grosse","year":"2020","unstructured":"Grosse J, Allado E, Roux C, Pierreisnard A, Couderc M, Clerc-Urmes I, et al. ACPA-positive versus ACPA-negative rheumatoid arthritis: two distinct erosive disease entities on radiography and ultrasonography. Rheumatol Int. 2020;40(4):615\u201324. https:\/\/doi.org\/10.1007\/s00296-019-04492-5.","journal-title":"Rheumatol Int"},{"issue":"4","key":"579_CR25","doi-asserted-by":"publisher","first-page":"393","DOI":"10.31138\/mjr.31.4.393","volume":"31","author":"A Minocha","year":"2020","unstructured":"Minocha A, Kukran S, Yee P, Nisar M. The differential effect of antibodies on radiographic progression in rheumatoid arthritis. Mediterr J Reumatol. 2020;31(4):393\u20139. https:\/\/doi.org\/10.31138\/mjr.31.4.393.","journal-title":"Mediterr J Reumatol"},{"issue":"2","key":"579_CR26","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/art.20006","volume":"50","author":"JD Gorman","year":"2004","unstructured":"Gorman JD, Lum RF, Chen JJ, Suarez-Almazor ME, Thomson G, Criswell LA. Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients. Arthritis Rheum. 2004;50(2):400\u201312. https:\/\/doi.org\/10.1002\/art.20006.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"579_CR27","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/1529-0131(200107)44:7<1529::AID-ART275>3.0.CO;2-P","volume":"44","author":"DL Mattey","year":"2001","unstructured":"Mattey DL, Hassell AB, Dawes PT, Cheung NT, Poulton KV, Thomson W, et al. Independent association of rheumatoid factor and the HLA\u2013DRB1 shared epitope with radiographic outcome in rheumatoid arthritis. Arthritis Rheum. 2001;44(7):1529\u201333. https:\/\/doi.org\/10.1002\/1529-0131(200107)44:7%3C1529::AID-ART275%3E3.0.CO;2-P.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"579_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13075-020-02413-7","volume":"23","author":"E Rydell","year":"2021","unstructured":"Rydell E, Forslind K, Nilsson J-\u00c5, Karlsson M, \u00c5kesson KE, Jacobsson LTH, et al. Predictors of radiographic erosion and joint space narrowing progression in patients with early rheumatoid arthritis: a cohort study. Arthritis Res Ther. 2021;23(1):27. https:\/\/doi.org\/10.1186\/s13075-020-02413-7.","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"579_CR29","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1136\/annrheumdis-2013-204601","volume":"74","author":"S Saevarsdottir","year":"2015","unstructured":"Saevarsdottir S, Rezaei H, Geborek P, Petersson I, Ernestam S, Albertsson K, et al. Current smoking status is a strong predictor of radiographic progression in early rheumatoid arthritis: results from the SWEFOT trial. Ann Rheum Dis. 2015;74(8):1509\u201314. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204601.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"579_CR30","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1002\/acr.25026","volume":"75","author":"L Alfredsson","year":"2023","unstructured":"Alfredsson L, Klareskog L, Hedstr\u00f6m AK. Influence of smoking on disease activity and quality of life in patients with rheumatoid arthritis: results from a Swedish Case-Control study with longitudinal Follow-Up. Arthritis Care Res (Hoboken). 2023;75(6):1269\u201377. https:\/\/doi.org\/10.1002\/acr.25026.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"579_CR31","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3899\/jrheum.180262","volume":"46","author":"MA Gianfrancesco","year":"2019","unstructured":"Gianfrancesco MA, Trupin L, Shiboski S, van der Laan M, Graf J, Imboden J, et al. Smoking is associated with higher disease activity in rheumatoid arthritis: A longitudinal study controlling for Time-varying covariates. J Rheumatol. 2019;46(4):370\u20135. https:\/\/doi.org\/10.3899\/jrheum.180262.","journal-title":"J Rheumatol"},{"issue":"1","key":"579_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/art.27758","volume":"63","author":"S Saevarsdottir","year":"2011","unstructured":"Saevarsdottir S, Wedr\u00e9n S, Seddighzadeh M, Bengtsson C, Wesley A, Lindblad S, et al. Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the epidemiological investigation of rheumatoid arthritis and the Swedish rheumatology register cohorts. Arthritis Rheum. 2011;63(1):26\u201336. https:\/\/doi.org\/10.1002\/art.27758.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"579_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/03009742.2011.599073","volume":"41","author":"MK S\u00f6derlin","year":"2012","unstructured":"S\u00f6derlin MK, Petersson IF, Geborek P. The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug. Scand J Rheumatol. 2012;41(1):1\u20139. https:\/\/doi.org\/10.3109\/03009742.2011.599073.","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"579_CR34","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315\u201324. https:\/\/doi.org\/10.1002\/art.1780310302.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"579_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1399-0039.1993.tb01970.x","volume":"41","author":"I Buyse","year":"1993","unstructured":"Buyse I, Decorte R, Baens M, Cuppens H, Semana G, Emonds MP, et al. Rapid DNA typing of class II HLA antigens using the polymerase chain reaction and reverse Dot blot hybridization. Tissue Antigens. 1993;41(1):1\u201314. https:\/\/doi.org\/10.1111\/j.1399-0039.1993.tb01970.x.","journal-title":"Tissue Antigens"},{"issue":"5","key":"579_CR36","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1399-0039.1992.tb01940.x","volume":"39","author":"O Olerup","year":"1992","unstructured":"Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens. 1992;39(5):225\u201335. https:\/\/doi.org\/10.1111\/j.1399-0039.1992.tb01940.x.","journal-title":"Tissue Antigens"},{"issue":"9","key":"579_CR37","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.55563\/clinexprheumatol\/vcfdjy","volume":"43","author":"EN Mole","year":"2025","unstructured":"Mole EN, Tarassi AE, Tsirogianni AG, Athanasiades TE, Kitsiou VE, Kouniaki DI, et al. Interaction of HLA-DRB1 shared epitope and smoking on the development of anti-citrullinated protein antibody positive rheumatoid arthritis in Greek patients. Clin Exp Rheumatol. 2025;43(9):1541\u20137. https:\/\/doi.org\/10.55563\/clinexprheumatol\/vcfdjy.","journal-title":"Clin Exp Rheumatol"},{"key":"579_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/03009742.2021.1917161","volume":"51","author":"GA Versteeg","year":"2021","unstructured":"Versteeg GA, Steunebrink LMM, Vonkeman H, ten Klooster P, Bijl AE, Laar M. Early radiological progression remains associated with long-term joint damage in real-world rheumatoid arthritis patients treated to the target of remission. Scand J Rheumatol. 2021;51:1\u201310. https:\/\/doi.org\/10.1080\/03009742.2021.1917161.","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"579_CR39","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13075-019-2030-8","volume":"21","author":"PM Ten Klooster","year":"2019","unstructured":"Ten Klooster PM, Versteeg LGA, Oude Voshaar MAH, de la Torre I, De Leonardis F, Fakhouri W, et al. Radiographic progression can still occur in individual patients with low or moderate disease activity in the current treat-to-target paradigm: real-world data from the Dutch rheumatoid arthritis monitoring (DREAM) registry. Arthritis Res Ther. 2019;21(1):237. https:\/\/doi.org\/10.1186\/s13075-019-2030-8.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"579_CR40","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/14397595.2019.1703484","volume":"31","author":"T Takeuchi","year":"2021","unstructured":"Takeuchi T, Soen S, Ishiguro N, Yamanaka H, Tanaka S, Kobayashi M, et al. Predictors of new bone erosion in rheumatoid arthritis patients receiving conventional synthetic disease-modifying antirheumatic drugs: analysis of data from the DRIVE and DESIRABLE studies. Mod Rheumatol. 2021;31(1):34\u201341. https:\/\/doi.org\/10.1080\/14397595.2019.1703484.","journal-title":"Mod Rheumatol"},{"issue":"6","key":"579_CR41","first-page":"861","volume":"23","author":"NG Papadopoulos","year":"2005","unstructured":"Papadopoulos NG, Alamanos Y, Voulgari PV, Epagelis EK, Tsifetaki N, Drosos AA. Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients? Clin Exp Rheumatol. 2005;23(6):861\u20136. PMID:16396705.","journal-title":"Clin Exp Rheumatol"},{"key":"579_CR42","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.mehy.2018.10.021","volume":"122","author":"D Murphy","year":"2019","unstructured":"Murphy D, Sinha-Royle E, Bellis K, Harrington C, Hutchinson D. Nodular rheumatoid arthritis (RA): A distinct disease subtype, initiated by cadmium inhalation inducing pulmonary nodule formation and subsequent RA-associated autoantibody generation. Med Hypotheses. 2019;122:48\u201355. https:\/\/doi.org\/10.1016\/j.mehy.2018.10.021.","journal-title":"Med Hypotheses"},{"issue":"1","key":"579_CR43","doi-asserted-by":"publisher","first-page":"268","DOI":"10.18632\/oncotarget.13613","volume":"8","author":"F Qiu","year":"2017","unstructured":"Qiu F, Liang CL, Liu H, Zeng YQ, Hou S, Huang S, et al. Impacts of cigarette smoking on immune responsiveness: up and down or upside down? Oncotarget. 2017;8(1):268\u201384. https:\/\/doi.org\/10.18632\/oncotarget.13613.","journal-title":"Oncotarget"},{"issue":"8","key":"579_CR44","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1136\/ard.2006.065060","volume":"66","author":"A Finckh","year":"2007","unstructured":"Finckh A, Dehler S, Costenbader KH, Gabay C. Cigarette smoking and radiographic progression in rheumatoid arthritis. Ann Rheum Dis. 2007;66(8):1066\u201371. https:\/\/doi.org\/10.1136\/ard.2006.065060.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"579_CR45","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1136\/ard.56.8.463","volume":"56","author":"KG Saag","year":"1997","unstructured":"Saag KG, Cerhan JR, Kolluri S, Ohashi K, Hunninghake GW, Schwartz DA. Cigarette smoking and rheumatoid arthritis severity. Ann Rheum Dis. 1997;56(8):463\u20139. https:\/\/doi.org\/10.1136\/ard.56.8.463.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"579_CR46","first-page":"630","volume":"27","author":"F Wolfe","year":"2000","unstructured":"Wolfe F. The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis. J Rheumatol. 2000;27(3):630\u20137. PMID:10743800.","journal-title":"J Rheumatol"},{"issue":"2","key":"579_CR47","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/1529-0131(200102)44:2<323::AID-ANR49>3.0.CO;2-C","volume":"44","author":"BJ Harrison","year":"2001","unstructured":"Harrison BJ, Silman AJ, Wiles NJ, Scott DGI, Symmons DPM. The association of cigarette smoking with disease outcome in patients with early inflammatory polyarthritis. Arthritis Rheum. 2001;44(2):323\u201330. https:\/\/doi.org\/10.1002\/1529-0131(200102)44:2%3C323::AID-ANR49%3E3.0.CO;2-C.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"579_CR48","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1002\/art.1780350705","volume":"35","author":"AA Drosos","year":"1992","unstructured":"Drosos AA, Lanchbury JS, Panayi GS, Moutsopoulos HM. Rheumatoid arthritis in Greek and British patients. A comparative clinical, radiologic, and serologic study. Arthritis Rheum. 1992;35(7):745\u20138. https:\/\/doi.org\/10.1002\/art.1780350705.","journal-title":"Arthritis Rheum"},{"issue":"Suppl 12","key":"579_CR49","first-page":"S7","volume":"13","author":"AA Drosos","year":"1995","unstructured":"Drosos AA, Moutsopoulos HM. Rheumatoid arthritis in greece: clinical, serological and genetic considerations. Clin Exp Rheumatol. 1995;13(Suppl 12):S7\u201312. PMID:8846545.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"579_CR50","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1053\/sarh.2002.31725","volume":"31","author":"JPA Ioannidis","year":"2002","unstructured":"Ioannidis JPA, Tarassi K, Papadopoulos IA, Voulgari PV, Boki KA, Papasteriades CA, et al. Shared epitopes and rheumatoid arthritis: disease associations in Greece and meta-analysis of mediterranean European populations. Semin Arthritis Rheum. 2002;31(6):361\u201370. https:\/\/doi.org\/10.1053\/sarh.2002.31725.","journal-title":"Semin Arthritis Rheum"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-025-00579-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-025-00579-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-025-00579-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:51:47Z","timestamp":1761904307000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcrheumatol.biomedcentral.com\/articles\/10.1186\/s41927-025-00579-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["579"],"URL":"https:\/\/doi.org\/10.1186\/s41927-025-00579-8","relation":{},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"25 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki and its subsequent amendments. Ethical approval was obtained from the Ethics Committee of the School of Medicine, National and Kapodistrian University of Athens, Greece (Protocol No. 180; Date of approval: 18 September 2019). Written informed consent was obtained from all participants or their legally authorized representatives, in line with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"128"}}